South Korea Biomedical non-woven textiles Market Size, Production, Sales, Average Product Price, Market Share 

South Korea Biomedical non-woven textiles Market Revenue Size and Production Analysis 

South Korea Biomedical non-woven textiles Market Size is expected to grow at an impressive rate during the timeframe (2024-2030). 

Rising Demand Backed by Expanding Patient Pool 

The South Korea Biomedical non-woven textiles market has emerged as one of the fastest-expanding healthcare sectors in the Asia-Pacific region, supported by both demographic shifts and technological advancements. For instance, the country reported over 16 million elderly individuals in 2024, accounting for more than 30% of its population aged above 65 years. This aging cohort has led to an increasing number of patients suffering from chronic conditions such as diabetes, hypertension, cardiovascular disorders, and cancer, which are estimated to affect more than 11 million patients combined. With hospitals like Seoul National University Hospital, Asan Medical Center, and Samsung Medical Center witnessing a rising flow of patients requiring surgical, wound care, and infection control products, the South Korea Biomedical non-woven textiles market has seen sales volumes expand consistently. By 2025, the South Korea Long term care device market size is forecast to reach nearly USD 2.3 billion, with a significant portion of that growth tied directly to disposable non-woven products such as surgical gowns, drapes, face masks, and wound dressings. The growing demand for Biomedical non-woven textiles in South Korea is also driven by the need for advanced infection-control solutions, particularly as the country handled more than 4.5 million annual surgical procedures in 2023 alone, a number expected to increase by 7% annually through 2030. 

Market Growth Driven by Infection Control and Chronic Disease Burden 

One of the strongest business drivers within the South Korea Biomedical non-woven textiles market is the rising emphasis on infection prevention and hospital-acquired infection (HAI) control. South Korea records nearly 1.2 million cases of HAIs every year, making non-woven medical textiles such as disposable masks, gowns, and sterilization wraps indispensable. The Ministry of Health has allocated more than USD 400 million annually toward infection prevention infrastructure, which creates a robust business case for manufacturers. For instance, Green Cross Medical and Kolon Industries have been expanding their product lines to meet hospital requirements for non-woven fabrics with antimicrobial coatings. Moreover, the prevalence of chronic diseases such as cancer, which affects nearly 280,000 new patients annually, and diabetes, which affects over 5 million individuals, has directly increased hospital admissions and, therefore, the consumption of disposable medical textiles. This surge in hospital visits and surgical requirements is projected to drive the South Korea Biomedical non-woven textiles market at a compound annual growth rate of nearly 8.5% between 2025 and 2032, creating opportunities worth over USD 3.5 billion in incremental sales during the forecast window. The rising demand for Biomedical non-woven textiles in South Korea is thus directly tied to the disease burden and the country’s efforts to modernize healthcare infrastructure. 

Opportunities Across Hospitals, Clinics, and Long-Term Care Facilities 

The expansion of long-term care services has become a critical growth opportunity for the South Korea Biomedical non-woven textiles market, as the South Korea Long term care device market size continues to expand rapidly. The country has more than 6,500 long-term care hospitals and facilities, serving nearly 1.7 million patients annually with chronic and degenerative diseases. These facilities represent a significant consumer segment for disposable bed linens, incontinence care products, patient gowns, and wound dressings, all of which are manufactured from non-woven textiles. For example, facilities under the National Health Insurance Service (NHIS) and the Korea Workers’ Compensation and Welfare Service have been key institutional buyers, generating steady orders for non-woven disposables. The long-term care sector alone is forecast to contribute nearly 25% of the total sales volume for non-woven medical textiles by 2030, representing one of the most lucrative segments for manufacturers and suppliers. The rising demand for Biomedical non-woven textiles in South Korea is also supported by changing patient expectations, where both healthcare workers and patients now prefer single-use, disposable, and hygienic textile products over reusable alternatives, citing convenience and reduced infection risks. This shift has created a unique business case for both domestic and multinational manufacturers to strengthen their presence in the South Korean healthcare ecosystem. 

Manufacturing, Innovation, and Strategic Investments 

The South Korea Biomedical non-woven textiles market is also being shaped by innovation and investment strategies pursued by both local and international players. Companies such as Toray Advanced Materials Korea, LG Chem, and Kolon Industries have increased their production capacities to meet surging hospital demand. For example, Toray expanded its Incheon facility in 2023, raising output capacity for spunbond and meltblown non-woven textiles by 25%. These expansions were largely driven by forecasted increases in surgical demand, projected to surpass 6 million annual cases by 2030, as well as the steady growth in elderly care facilities. Moreover, the market has been attracting foreign entrants from Japan and the US, who see South Korea as a hub for supplying not just domestic hospitals but also export markets in Southeast Asia. The South Korea Long term care device market size has further enhanced the attractiveness of investment, as suppliers diversify their product portfolios to include wound dressings, surgical packs, face masks, and incontinence care solutions. From a business perspective, the South Korea Biomedical non-woven textiles market is positioned as a dynamic sector with multiple revenue streams, backed by both policy-driven healthcare modernization and consumer-driven preference for high-quality disposable medical products. 

Forecast Outlook and Strategic Market Positioning 

Looking ahead, the South Korea Biomedical non-woven textiles market is projected to continue its robust growth trajectory, reaching an estimated value of USD 5.8 billion by 2032, driven by consistent demand across hospitals, ambulatory surgical centers, and long-term care facilities. The demand for Biomedical non-woven textiles in South Korea is forecast to grow by more than 12% annually in surgical textiles and 10% annually in wound care applications, creating one of the most attractive opportunities in Asia. For instance, government-led initiatives to modernize 400 hospitals under the Smart Hospital Program by 2028 are expected to generate contracts worth over USD 700 million for non-woven textile suppliers. Similarly, the country’s efforts to strengthen medical tourism, which drew more than 600,000 international patients in 2024, is expected to further boost hospital usage of disposable gowns, drapes, and wound care materials. The expanding South Korea Long term care device market size, set to cross USD 3 billion by 2032, will further strengthen the business case for manufacturers. In summary, the South Korea Biomedical non-woven textiles market is strategically positioned for sustained expansion, offering ample growth opportunities for both domestic and multinational suppliers seeking to capture a share of South Korea’s evolving healthcare demand. 

South Korea Biomedical Non-Woven Textiles Market – Innovations, Healthcare Integration, and Strategic Outlook (2023–2035) 

Executive Industry Perspective 

1.1 Current Landscape of Biomedical Textiles in South Korea
1.2 Key Healthcare Growth Drivers and Market Catalysts
1.3 Market Highlights and Strategic Insights 

National Healthcare Policy and Industry Alignment 

2.1 Role of Biomedical Non-Woven Textiles in Public Health Programs
2.2 Government Support, Subsidies, and Policy Interventions 

Scope, Definitions, and Research Framework 

3.1 Product Classification: Disposable, Durable, and Smart Non-Woven Textiles
3.2 Research Methodology, Data Validation, and Forecasting Approach 

Healthcare Infrastructure and Demand Drivers 

4.1 Utilization in Public Hospitals and Medical Institutions
4.2 Role of Private Clinics and Specialty Centers
4.3 Expansion into Home Healthcare and Long-Term Care Facilities 

Market Segmentation by Product Category 

5.1 Surgical Gowns, Drapes, and Sterile Coverings
5.2 Face Masks, Respirators, and Infection Control Apparel
5.3 Advanced Wound Care and Hygiene Products
5.4 Innovative Smart and Biodegradable Non-Woven Solutions 

Clinical Application and End-User Insights 

6.1 Hospitals and Medical Centers
6.2 Home Healthcare and Elderly Care
6.3 Research Institutes and Academic Organizations 

Technological Developments and Material Advancements 

7.1 Traditional Non-Woven Textiles vs. Advanced Functional Materials
7.2 Nanotechnology, Antimicrobial Coatings, and Smart Fibers 

Market Dynamics and Strategic Forces 

8.1 Growth Drivers: Rising Surgical Procedures, Infection Control, Aging Population
8.2 Challenges: Import Dependence, Pricing Pressures, Waste Management
8.3 Opportunities: Localization of Production, Export Expansion, R&D Collaboration 

Regulatory Environment and Quality Compliance 

9.1 South Korean FDA and Healthcare Standards
9.2 Global Accreditation and International Certification Requirements 

Procurement and Supply Chain Practices 

10.1 Public Sector Procurement: Government Tenders and Contracts
10.2 Private Sector Distribution Networks and Direct Sales Models 

Cost Structures and Pricing Trends 

11.1 Raw Material Costs and Price Sensitivities
11.2 Cost Optimization through Local Manufacturing 

Workforce Training and Technical Competence 

12.1 Training Programs for Healthcare Workers on Biomedical Textile Usage
12.2 Capacity Building for Manufacturing Staff
12.3 Continuous Skill Upgradation Initiatives 

Regional Market Insights 

13.1 Demand Concentration in Seoul and Metropolitan Areas
13.2 Expansion to Regional Healthcare Hubs 

Maintenance, Sterilization, and Reusability Practices 

14.1 Local Facilities for Cleaning and Sterile Reuse
14.2 Innovations in Disposable and Eco-Friendly Products 

Logistics and Distribution Analysis 

15.1 Import, Warehousing, and Distribution Channels
15.2 Addressing Challenges in Cold Chain and Timely Deliveries 

Strategic Growth Pathways 

16.1 Customization of Products for Local Clinical Needs
16.2 Partnerships with Hospitals for Pilot Implementations 

Clinical Outcomes and Healthcare Impact 

17.1 Enhancing Patient Safety and Surgical Efficiency
17.2 Documented Benefits in Infection Prevention 

Environmental and Sustainability Dimensions 

18.1 Biodegradable and Eco-Friendly Non-Woven Materials
18.2 Waste Reduction and Recycling Initiatives 

Future Technology and Market Outlook 

19.1 AI-Enabled Production and Smart Non-Woven Integration
19.2 Digital Healthcare and Remote Patient Monitoring Applications 

Global Collaboration and Knowledge Exchange 

20.1 Partnerships with International Biomedical Textile Companies
20.2 Cross-Border Research and Standardization Practices 

Competitive Landscape and Industry Positioning 

21.1 Key Domestic and International Manufacturers in South Korea
21.2 Market Share Dynamics and Competitive Strategies 

Market Forecast and Growth Projections 

22.1 Forecast by Product Type, Application, and End-User Segments
22.2 South Korea Biomedical Non-Woven Textiles Market Outlook to 2035 

Strategic Recommendations for Industry Stakeholders 

23.1 Enhancing R&D Investments and Manufacturing Capacity
23.2 Market Entry, Expansion, and Export-Oriented Strategies 

Case Studies and Benchmark Implementations 

24.1 Successful Deployments in South Korean Hospitals and Clinics
24.2 Best Practices Driving Improved Healthcare Outcomes 

Vision 2035 – Building a Resilient Biomedical Textile Ecosystem 

25.1 Roadmap to Align with National Healthcare Goals
25.2 Establishing South Korea as a Global Leader in Biomedical Non-Woven Innovation 

 

  

  

About South Korea Demography: